Evolent Health, Inc. announced that a new director nominee will stand for election to the Board of Directors at the annual meeting of stockholders scheduled to be held on June 8, 2023. The company announced that Mr. David Farner tendered his resignation from the Board, pursuant to the stockholder's agreement between Evolent and the University of Pittsburgh Medical Center (UPMC). Mr. Farner — a UPMC designated director — will serve out the remainder of his current term through Evolent's annual meeting in June.

Mr. Farner's departure from the Board is in addition to the previously announced departure of former Chairman and CEO Frank J. Williams, an Evolent co-founder. Mr. Williams will retire from the Board also in June.